Dr Reddys Laboratories Q4 Results

  • BSE: 500124
  • NSE: DRREDDY
  • ISIN: INE089A01023
  • Sector: Biotechnology & Drugs
BSE
6,721.65125.85 (1.91%)
Volume14.83 K
Updated: Fri 12 Jul, 2024 | 15:43:11
NSE
6,719.45124.70 (1.89%)
Volume5.89 L
Updated: Fri 12 Jul, 2024 | 15:50:17
Today: 6,564.85
6,741.90
52-Wk: 5,077.70
6,741.90

Q4 Results Highlights

  • Total Income
    ₹7,113.80 Cr.
    (12.65%)
  • Operating Profit
    ₹1,463.50 Cr.
    (20.11%)
  • Profit After Tax
    ₹1,309.80 Cr.
    (36.41%)
  • Operating Margin
    20.57%
    (6.62%)
Note: Comparison is on YoY basis

Quarterly - Dr Reddys Laboratories Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
Total Revenue 7,113.806,789.80-1.70%6,315.2012.65%
Selling/ General/ Admin Expenses Total 3,207.802,836.505.98%2,829.2013.38%
Depreciation/ Amortization 367.70323.70-1.55%315.5016.55%
Total Operating Expense 5,650.305,175.001.13%5,096.7010.86%
Operating Income 1,463.501,614.80-11.28%1,218.5020.11%
Net Income Before Taxes 1,605.201,637.70-12.24%1,329.2020.76%
Net Income 1,309.801,243.90-5.15%960.2036.41%
Diluted Normalized EPS 77.6875.37-6.75%60.0129.45%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts